Pandemic Influenza Vaccines – The Challenges
AbstractRecent years’ enzootic spread of highly pathogenic H5N1 virus among poultry and the many lethal zoonoses in its wake has stimulated basic and applied pandemic vaccine research. The quest for an efficacious, affordable and timely accessible pandemic vaccine has been high on the agenda. When a variant H1N1 strain of swine origin emerged as a pandemic virus, it surprised many, as this subtype is well-known to man as a seasonal virus. This review will cover some difficult vaccine questions, such as the immunological challenges, the new production platforms, and the limited supply and global equity issues. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Haaheim, L.R.; Madhun, A.S.; Cox, R. Pandemic Influenza Vaccines – The Challenges. Viruses 2009, 1, 1089-1109.
Haaheim LR, Madhun AS, Cox R. Pandemic Influenza Vaccines – The Challenges. Viruses. 2009; 1(3):1089-1109.Chicago/Turabian Style
Haaheim, Lars R.; Madhun, Abdullah S.; Cox, Rebecca. 2009. "Pandemic Influenza Vaccines – The Challenges." Viruses 1, no. 3: 1089-1109.